Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Reflect Scientific, Inc.

RSCFPNK
Healthcare
Medical - Instruments & Supplies
$0.05
$0.00(0.00%)
U.S. Market opens in 1h 37m

Reflect Scientific, Inc. Fundamental Analysis

Reflect Scientific, Inc. (RSCF) shows weak financial fundamentals with a PE ratio of 58.46, profit margin of 5.26%, and ROE of 3.47%. The company generates $0.0B in annual revenue with strong year-over-year growth of 73.77%.

Key Strengths

Cash Position42.02%
PEG Ratio-1.24
Current Ratio3.90

Areas of Concern

ROE3.47%
Operating Margin2.54%
We analyze RSCF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 56.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C
56.8/100

We analyze RSCF's fundamental strength across five key dimensions:

Efficiency Score

Weak

RSCF struggles to generate sufficient returns from assets.

ROA > 10%
2.56%

Valuation Score

Moderate

RSCF shows balanced valuation metrics.

PE < 25
58.46
PEG Ratio < 2
-1.24

Growth Score

Moderate

RSCF shows steady but slowing expansion.

Revenue Growth > 5%
73.77%
EPS Growth > 10%
1.37%

Financial Health Score

Excellent

RSCF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.06
Current Ratio > 1
3.90

Profitability Score

Weak

RSCF struggles to sustain strong margins.

ROE > 15%
3.47%
Net Margin ≥ 15%
5.26%
Positive Free Cash Flow
No

Key Financial Metrics

Is RSCF Expensive or Cheap?

P/E Ratio

RSCF trades at 58.46 times earnings. This suggests a premium valuation.

58.46

PEG Ratio

When adjusting for growth, RSCF's PEG of -1.24 indicates potential undervaluation.

-1.24

Price to Book

The market values Reflect Scientific, Inc. at 1.99 times its book value. This may indicate undervaluation.

1.99

EV/EBITDA

Enterprise value stands at 52.30 times EBITDA. This signals the market has high growth expectations.

52.30

How Well Does RSCF Make Money?

Net Profit Margin

For every $100 in sales, Reflect Scientific, Inc. keeps $5.26 as profit after all expenses.

5.26%

Operating Margin

Core operations generate 2.54 in profit for every $100 in revenue, before interest and taxes.

2.54%

ROE

Management delivers $3.47 in profit for every $100 of shareholder equity.

3.47%

ROA

Reflect Scientific, Inc. generates $2.56 in profit for every $100 in assets, demonstrating efficient asset deployment.

2.56%

Following the Money - Real Cash Generation

Operating Cash Flow

Reflect Scientific, Inc. generates limited operating cash flow of $-8.16K, signaling weaker underlying cash strength.

$-8.16K

Free Cash Flow

Reflect Scientific, Inc. generates weak or negative free cash flow of $-8.16K, restricting financial flexibility.

$-8.16K

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

RSCF converts -0.20% of its market value into free cash.

-0.20%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

58.46

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-1.24

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.99

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.90

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

0.02

vs 25 benchmark

How RSCF Stacks Against Its Sector Peers

MetricRSCF ValueSector AveragePerformance
P/E Ratio58.4628.25 Worse (Expensive)
ROE3.47%780.00% Weak
Net Margin5.26%-20122.00% (disorted) Weak
Debt/Equity0.060.30 Strong (Low Leverage)
Current Ratio3.904.66 Strong Liquidity
ROA2.56%-14687.00% (disorted) Weak

RSCF outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Reflect Scientific, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

7.72%

Industry Style: Defensive, Growth, Innovation

Growing

EPS CAGR

179.52%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

0.00%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ